Is the new drug lecanemab a breakthrough for Alzheimer’s?
Published
Results of a phase three Alzheimer's drug trial appeared to slow progression of the disease. But how effective is lecanemab really?
Full ArticlePublished
Results of a phase three Alzheimer's drug trial appeared to slow progression of the disease. But how effective is lecanemab really?
Full ArticleLecanemab has been shown in trials to slow the progress of early-stage Alzheimer's by 27%
It's been hailed as a momentous breakthrough after decades of failure in the search for effective treatment